Global Methylcobalamin Market 2024-2030
  • CHOOSE LICENCE TYPE
Consulting Services
    How will you benefit from our consulting services ?

Global Methylcobalamin Market 2024-2030

Last Updated:  Apr 25, 2025 | Study Period: 2024-2030

METHYLCOBALAMIN MARKET

 

INTRODUCTION METHYLCOBALAMIN MARKET

Methylcobalamin (mecobalamin, MeCbl, or MeB12) is acobalamin, a form ofvitamin B12. It differs fromcyanocobalaminin that thecyano groupat the cobalt is replaced with amethyl group.

 

Methylcobalamin features an octahedral cobalt(III) centre and can be obtained as bright red crystals. From the perspective ofcoordination chemistry, methylcobalamin is notable as a rare example of a compound that contains metal–alkyl bonds.Nickel–methyl intermediates have been proposed for the final step ofmethanogenesis.

 

Methylcobalamin is equivalent physiologically to vitamin B12,and can be used to prevent or treat pathology arising from a lack of vitamin B12intake (vitamin B12deficiency).

 

Methylcobalamin is also used in the treatment ofperipheral neuropathy,diabetic neuropathy, and as a preliminary treatment foramyotrophic lateral sclerosis.

 

Methylcobalamin that is ingested is not used directly as a cofactor, but is first converted byMMACHCinto cob(II)alamin.

 

Cob(II)alamin is then later converted into the other two forms, adenosylcobalamin and methylcobalamin for use as cofactors. That is, methylcobalamin is first dealkylated and then regenerated.

 

METHYLCOBALAMIN MARKET SIZE AND FORECAST

 

infographic: Methylcobalamin Market, Methylcobalamin Market Size, Methylcobalamin Market Trends, Methylcobalamin Market Forecast, Methylcobalamin Market Risks, Methylcobalamin Market Report, Methylcobalamin Market Share

 

The Global METHYLCOBALAMIN market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

 

METHYLCOBALAMIN MARKET NEW PRODUCT LAUNCH

Pregabalin 75 mg and Methylcobalamin 750 mcg Capsule 10's - Pregabalin 75 mg and Methylcobalamin 750 mcg Capsule 10's belongs to the class of medications ‘anticonvulsants’ used in the treatment of neuropathic pain. Neuropathic pain is a chronic (long-term) progressive nerve disease that causes nerve pain due to nerve damage or the nervous system's malfunctioning.

 

It is mostly seen in patients who had suffered a trauma or nerve injury, diabetes, vitamin deficiencies, cancer, multiple sclerosis (disease of the brain and spinal cord), shingles (a viral infection), and HIV.

 

Pregabalin 75 mg and Methylcobalamin 750 mcg Capsule 10's is a combination of two medicines: Pregabalin and Methylcobalamin.

 

Pregabalin acts by decreasing the pain signals sent by a damaged nerve in the body. On the other hand, Methylcobalamin helps rejuvenate and protect damaged nerve cells by producing a substance called myelin (outer protective layer of nerve cell - neuron).

 

Pregabalin is an anticonvulsant that affects the brain's chemicals that send pain signals across the nervous system. It works by binding to the specific site on voltage-gated calcium channels (responsible for excitatory response), thereby decreasing brain activity.

 

This effect helps in relieving nerve pain and lowers the risk of seizures. On the other hand, Methylcobalamin is a form of vitamin B12 that helps rejuvenate and protect damaged nerve cells by producing a substance called myelin (outer protective layer of nerve cells).

 

Together, Pregabalin 75 mg and Methylcobalamin 750 mcg Capsule 10's helps in providing relief from neuropathic pain and improved nerve signal conduction.  

 

METHYLCOBALAMIN MARKET COMPANY PROFILE

  • Pregablin
  • Zydus
  • Cipla
  • TAK
  • Emcure 

 

THIS METHYLCOBALAMIN MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

  1. How many Methylcobalamin are manufactured per annum globally? Who are the sub-component suppliers in different regions?
  2. Cost breakup of a Global Methylcobalamin and key vendor selection criteria
  3. Where is the Methylcobalamin manufactured? What is the average margin per unit?
  4. Market share of Global Methylcobalamin market manufacturers and their upcoming products
  5. Cost advantage for OEMs who manufacture Global Methylcobalamin in-house
  6. key predictions for next 5 years in Global Methylcobalamin market
  7. Average B-2-B Methylcobalamin market price in all segments
  8. Latest trends in Methylcobalamin market, by every market segment
  9. The market size (both volume and value) of the Methylcobalamin market in 2024-2030 and every year in between?
  10. Production breakup of Methylcobalamin market, by suppliers and their OEM relationship
Sl noTopic
1Market Segmentation
2Scope of the report
3Abbreviations
4Research Methodology
5Executive Summary
6Introduction
7Insights from Industry stakeholders
8Cost breakdown of Product by sub-components and average profit margin
9Disruptive innovation in the Industry
10Technology trends in the Industry
11Consumer trends in the industry
12Recent Production Milestones
13Component Manufacturing in US, EU and China
14COVID-19 impact on overall market
15COVID-19 impact on Production of components
16COVID-19 impact on Point of sale
17Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
18Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
19Market Segmentation, Dynamics and Forecast by Application, 2024-2030
20Market Segmentation, Dynamics and Forecast by End use, 2024-2030
21Product installation rate by OEM, 2023
22Incline/Decline in Average B-2-B selling price in past 5 years
23Competition from substitute products
24Gross margin and average profitability of suppliers
25New product development in past 12 months
26M&A in past 12 months
27Growth strategy of leading players
28Market share of vendors, 2023
29Company Profiles
30Unmet needs and opportunity for new suppliers
31Conclusion
32Appendix